Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast in dry eye disease (OPUS-2)
NCT01743729Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lifitegrast in dry eye disease (DED), sponsored by Takeda. Started Dec 2012; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01743729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743729.